Complement activation in patients with neuromyelitis optica

Complement activation in patients with neuromyelitis optica

Show other versions (1)

The role of complement has been demonstrated in experimental models of neuromyelitis optica (NMO), however, only few studies have analysed complement components longitudinally in NMO patients. We measured serum or plasma concentrations of anti-C1q antibodies and complement split products C3a and C4a...

Full description

Bibliographic Details
Main Authors:	Nytrova, P, Potlukova, E, Kemlink, D, Woodhall, M, Horakova, D, Waters, P, Havrdova, E, Zivorova, D, Vincent, A, Trendelenburg, M
Format:	Journal article
Language:	English
Published:	Elsevier 2014

Similar Items

Complement activation in patients with neuromyelitis optica.
by: Nytrova, P, et al.
Published: (2014)

C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
by: Nytrova, P, et al.
Published: (2013)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
by: Saadoun, S, et al.
Published: (2010)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2008)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
by: Kitley, J, et al.
Published: (2012)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
by: Woodhall, M, et al.
Published: (2013)

Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
by: Damato, V, et al.
Published: (2019)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
by: Nour, M, et al.
Published: (2014)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
by: Absoud, M, et al.
Published: (2014)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
by: Tackley, G, et al.
Published: (2016)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
by: Kitley, J, et al.
Published: (2013)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
by: Min, J, et al.
Published: (2013)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
by: Jarius, S, et al.
Published: (2008)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
by: Cavus, F, et al.
Published: (2013)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2007)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
by: Kitley, J, et al.
Published: (2011)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
by: Kitley, J, et al.
Published: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
by: Kitley, J, et al.
Published: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
by: Kim, S, et al.
Published: (2013)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
by: Kitley, J, et al.
Published: (2013)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
by: Jarius, S, et al.
Published: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
by: Viegas, S, et al.
Published: (2009)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
by: Akman-Demir, G, et al.
Published: (2011)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
by: Waters, P, et al.
Published: (2008)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
by: Saadoun, S, et al.
Published: (2013)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
by: Kitley, J, et al.
Published: (2012)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
by: Sato, D, et al.
Published: (2014)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
by: Saadoun, S, et al.
Published: (2013)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
by: Kim, B, et al.
Published: (2010)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
by: Leite, M, et al.
Published: (2009)

NMO-IgG in the diagnosis of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2007)

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
by: Damato, V, et al.
Published: (2022)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
by: Waters, P, et al.
Published: (2008)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
by: Kitley, J, et al.
Published: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
by: Kitley, J, et al.
Published: (2014)

Treatment of Neuromyelitis Optica: Review and Recommendations.
by: Kimbrough, D, et al.
Published: (2012)